BIORA THERAPEUTICS INC - COM NEW (BIOR)

CUSIP: 74319F305

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM NEW
Total 13F shares
3,440,789
Share change
+1,107,842
Total reported value
$13,246,393
Put/Call ratio
5.9%
Price per share
$3.85
Number of holders
31
Value change
+$4,298,684
Number of buys
14
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 74319F305?
CUSIP 74319F305 identifies BIOR - BIORA THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIORA THERAPEUTICS INC - COM NEW (BIOR) as of Q2 2023

As of 30 Jun 2023, BIORA THERAPEUTICS INC - COM NEW (BIOR) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,440,789 shares. The largest 10 holders included Athyrium Capital Management, LP, Anson Funds Management LP, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Schonfeld Strategic Advisors LLC, GSA CAPITAL PARTNERS LLP, STATE STREET CORP, and Creative Planning. This page lists 31 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.